177 related articles for article (PubMed ID: 16917117)
1. Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension.
Dewachter L; Adnot S; Fadel E; Humbert M; Maitre B; Barlier-Mur AM; Simonneau G; Hamon M; Naeije R; Eddahibi S
Am J Respir Crit Care Med; 2006 Nov; 174(9):1025-33. PubMed ID: 16917117
[TBL] [Abstract][Full Text] [Related]
2. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
3. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
Eddahibi S; Guignabert C; Barlier-Mur AM; Dewachter L; Fadel E; Dartevelle P; Humbert M; Simonneau G; Hanoun N; Saurini F; Hamon M; Adnot S
Circulation; 2006 Apr; 113(15):1857-64. PubMed ID: 16606791
[TBL] [Abstract][Full Text] [Related]
4. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension.
Sanchez O; Marcos E; Perros F; Fadel E; Tu L; Humbert M; Dartevelle P; Simonneau G; Adnot S; Eddahibi S
Am J Respir Crit Care Med; 2007 Nov; 176(10):1041-7. PubMed ID: 17823354
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
6. Role of angiopoietin-1 in experimental and human pulmonary arterial hypertension.
Kugathasan L; Dutly AE; Zhao YD; Deng Y; Robb MJ; Keshavjee S; Stewart DJ
Chest; 2005 Dec; 128(6 Suppl):633S-642S. PubMed ID: 16373885
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.
Kobayashi H; DeBusk LM; Babichev YO; Dumont DJ; Lin PC
Blood; 2006 Aug; 108(4):1260-6. PubMed ID: 16638932
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction.
Nishishita T; Lin PC
J Cell Biochem; 2004 Feb; 91(3):584-93. PubMed ID: 14755687
[TBL] [Abstract][Full Text] [Related]
10. The angiopoietin-tie2 system in coronary artery endothelium prevents oxidized low-density lipoprotein-induced apoptosis.
Kim I; Moon SO; Han CY; Pak YK; Moon SK; Kim JJ; Koh GY
Cardiovasc Res; 2001 Mar; 49(4):872-81. PubMed ID: 11230987
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia.
Tammela T; Saaristo A; Lohela M; Morisada T; Tornberg J; Norrmén C; Oike Y; Pajusola K; Thurston G; Suda T; Yla-Herttuala S; Alitalo K
Blood; 2005 Jun; 105(12):4642-8. PubMed ID: 15746084
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
13. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
[TBL] [Abstract][Full Text] [Related]
14. Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF.
Metheny-Barlow LJ; Tian S; Hayes AJ; Li LY
Microvasc Res; 2004 Nov; 68(3):221-30. PubMed ID: 15501241
[TBL] [Abstract][Full Text] [Related]
15. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
17. Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.
Izikki M; Guignabert C; Fadel E; Humbert M; Tu L; Zadigue P; Dartevelle P; Simonneau G; Adnot S; Maitre B; Raffestin B; Eddahibi S
J Clin Invest; 2009 Mar; 119(3):512-23. PubMed ID: 19197140
[TBL] [Abstract][Full Text] [Related]
18. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.
Satchell SC; Harper SJ; Tooke JE; Kerjaschki D; Saleem MA; Mathieson PW
J Am Soc Nephrol; 2002 Feb; 13(2):544-550. PubMed ID: 11805186
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the expression of Ang1, Ang2, and Tie2 in the Corpus Cavernosum of the rat during aging.
Cordeiro AL; Figueiredo A; Tomada I; de Almeida H; Neves D
Microsc Microanal; 2010 Dec; 16(6):699-709. PubMed ID: 20969813
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes.
Park YS; Kim NH; Jo I
Microvasc Res; 2003 Mar; 65(2):125-31. PubMed ID: 12686170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
